Invention Grant
- Patent Title: Anti-LSP1 antibody
-
Application No.: US16341529Application Date: 2017-10-13
-
Publication No.: US10968281B2Publication Date: 2021-04-06
- Inventor: Elodie Segura , Sebastian Amigorena , Franck Perez , Sandrine Moutel
- Applicant: INSTITUT CURIE , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Applicant Address: FR Paris; FR Paris; FR Paris
- Assignee: INSTITUT CURIE,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Current Assignee: INSTITUT CURIE,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Current Assignee Address: FR Paris; FR Paris; FR Paris
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP16306355 20161014
- International Application: PCT/EP2017/076139 WO 20171013
- International Announcement: WO2018/069480 WO 20180419
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; G01N33/53 ; C07K16/46 ; C07K16/00 ; C07K16/30 ; G01N33/50 ; A61K38/00
Abstract:
The present invention provides a new anti-LSP1 (Leukocyte specific protein 1) antibody. This new antibody allows the specific staining of inflammatory dendritic cells and can be used in diagnosis methods or as a medicament when conjugated to a drug.
Information query
